Literature DB >> 24299932

A randomized controlled trial of variable rate phenylephrine infusion with rescue phenylephrine boluses versus rescue boluses alone on physician interventions during spinal anesthesia for elective cesarean delivery.

Sahar M Siddik-Sayyid1, Samar K Taha, Ghassan E Kanazi, Marie T Aouad.   

Abstract

BACKGROUND: Phenylephrine infusion is used to reduce hypotension during spinal anesthesia for cesarean delivery. A prophylactic fixed rate infusion regimen may not improve hemodynamic control; a variable rate regimen adjusted in response to changes in arterial blood pressure and heart rate may allow more accurate maintenance of baseline blood pressure. We hypothesized that a combination of crystalloid solution coload with a variable rate phenylephrine infusion and phenylephrine rescue boluses may be associated with fewer physician interventions needed to maintain maternal systolic blood pressure within 20% of baseline and greater hemodynamic stability than crystalloid solution coload with phenylephrine rescue boluses alone.
METHODS: In this prospective, double-blind study, 80 patients received a coload with 15 mL/kg lactated Ringer's solution immediately after the initiation of spinal anesthesia. Patients were randomized to receive a prophylactic variable rate phenylephrine infusion starting at 0.75 μg/kg/min (group P) or infusion of normal saline (group S). Maternal systolic blood pressure was maintained within 20% of baseline with rescue phenylephrine boluses using a preset algorithm. During the predelivery period, the number of physician interventions (primary outcome), hemodynamic performance, nausea/vomiting, and umbilical cord blood gas values were compared between the groups.
RESULTS: One patient from group S was excluded due to protocol violation. Therefore, group P included 40 patients and group S 39 patients. The median (range) number of physician interventions needed to maintain maternal hemodynamics within the target range (0 [0-6] vs 3 [0-9], difference in median: 3, 95% confidence interval of difference: 2-4) and incidence of hypotension (8/40 [20%] vs 35/39 [90%]) were lower in group P compared with group S (P < 0.001). Group P had a higher incidence of hypertension compared with group S (6/40 [15%] vs 0/39 [0%], P = 0.026). The median performance error was closer to baseline (P < 0.001) with a smaller median absolute performance error (P = 0.001) in group P versus group S. In group P, 4/40 (10%) patients had nausea/vomiting compared with 17/39 (44%) in group S (P = 0.001). The number needed to treat was 1.4 women to prevent 1 case of hypotension, and 3 women to prevent 1 case of nausea/vomiting; the rate of hypertension was 1 case per 6.7 women treated. Neonatal outcomes were not different between the 2 groups.
CONCLUSION: Prophylactic variable rate phenylephrine infusion and rescue phenylephrine bolus dosing is more effective than relying on rescue phenylephrine bolus dosing with respect to limiting clinician workload and maternal symptoms during spinal anesthesia for cesarean delivery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24299932     DOI: 10.1213/01.ane.0000437731.60260.ce

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  10 in total

Review 1.  Vasopressors in obstetric anesthesia: A current perspective.

Authors:  Deb Sanjay Nag; Devi Prasad Samaddar; Abhishek Chatterjee; Himanshu Kumar; Ankur Dembla
Journal:  World J Clin Cases       Date:  2015-01-16       Impact factor: 1.337

Review 2.  [Recent standards in management of obstetric anesthesia].

Authors:  Maximiliaan van Erp; Clemens Ortner; Stefan Jochberger; Klaus Ulrich Klein
Journal:  Wien Med Wochenschr       Date:  2017-07-25

3.  A randomized trial of phenylephrine infusion versus bolus dosing for nausea and vomiting during Cesarean delivery in obese women.

Authors:  Ronald B George; Dolores M McKeen; Jennifer E Dominguez; Terrence K Allen; Patricia A Doyle; Ashraf S Habib
Journal:  Can J Anaesth       Date:  2017-12-05       Impact factor: 5.063

4.  A Clinical Trial on the Effects of Different Regimens of Phenylephrine on Maternal Hemodynamic After Spinal Anesthesia for Cesarean Section.

Authors:  Mahshid Nikooseresht; Mohammad Ali Seifrabiei; Pouran Hajian; Shadab Khamooshi
Journal:  Anesth Pain Med       Date:  2020-07-19

5.  Techniques for preventing hypotension during spinal anaesthesia for caesarean section.

Authors:  Cheryl Chooi; Julia J Cox; Richard S Lumb; Philippa Middleton; Mark Chemali; Richard S Emmett; Scott W Simmons; Allan M Cyna
Journal:  Cochrane Database Syst Rev       Date:  2020-07-01

6.  Combined use of hyperbaric and hypobaric ropivacaine significantly improves hemodynamic characteristics in spinal anesthesia for caesarean section: a prospective, double-blind, randomized, controlled study.

Authors:  ZheFeng Quan; Ming Tian; Ping Chi; Xin Li; HaiLi He; Chao Luo
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

7.  Peri-arrest bolus epinephrine practices amongst pediatric resuscitation experts.

Authors:  Catherine E Ross; Margaret M Hayes; Monica E Kleinman; Michael W Donnino; Amy M Sullivan
Journal:  Resusc Plus       Date:  2022-01-14

8.  Phenylephrine infusion for spinal-induced hypotension in elective cesarean delivery: Does preload make a difference?

Authors:  Brandi A Bottiger; Dmitri S Bezinover; Berend Mets; Priti G Dalal; Jansie Prozesky; Serdar Ural; Sonia Vaida
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Jul-Sep

9.  Study Comparing Phenylephrine Bolus and Infusion for Maternal Hypotension and Neonatal Outcome during Cesarean Section under Spinal Anesthesia.

Authors:  Manish Choudhary; Jeetendra Kumar Bajaj
Journal:  Anesth Essays Res       Date:  2018 Apr-Jun

10.  Variable versus fixed-rate infusion of phenylephrine during cesarean delivery: a randomized controlled trial.

Authors:  Ahmed Hasanin; Sara Habib; Yaser Abdelwahab; Mohamed Elsayad; Maha Mostafa; Marwa Zayed; Mohamed Maher Kamel; Kareem Hussein; Sherin Refaat; Ahmed Y Fouda; Ahmed A Wali; Khaled A Elshafaei; Doaa Mahmoud; Sarah Amin
Journal:  BMC Anesthesiol       Date:  2019-11-03       Impact factor: 2.217

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.